Somatostatin receptors (SSTR) are a family of integral membrane glycoproteins, that have been effectively targeted using SST agonists and antagonists in different cancer types, including neuroblastoma, meningioma, low-grade gliomas and glioblastoma multiforme (GBM). This evidence concerns the gene SST and glioblastoma.